Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

[Who should supervise anticoagulant treatment and how?]

Smadja DM, Gendron N, Sanchez O; groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE.

Rev Mal Respir. 2019 Oct 11. pii: S0761-8425(19)30213-X. doi: 10.1016/j.rmr.2019.06.002. [Epub ahead of print] French. No abstract available.

PMID:
31611030
2.

[Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version].

Sanchez O, Benhamou Y, Bertoletti L, Constans J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Jul 4. pii: S0761-8425(19)30210-4. doi: 10.1016/j.rmr.2019.05.038. [Epub ahead of print] French. No abstract available.

PMID:
31280989
3.

Standardization of methods to quantify and culture endothelial colony-forming cells derived from peripheral blood: Position paper from the International Society on Thrombosis and Haemostasis SSC.

Smadja DM, Melero-Martin JM, Eikenboom J, Bowman M, Sabatier F, Randi AM.

J Thromb Haemost. 2019 Jul;17(7):1190-1194. doi: 10.1111/jth.14462. Epub 2019 May 22. No abstract available.

PMID:
31119878
4.

Human Endothelial Colony Forming Cells Express Intracellular CD133 that Modulates their Vasculogenic Properties.

Rossi E, Poirault-Chassac S, Bieche I, Chocron R, Schnitzler A, Lokajczyk A, Bourdoncle P, Dizier B, Bacha NC, Gendron N, Blandinieres A, Guerin CL, Gaussem P, Smadja DM.

Stem Cell Rev Rep. 2019 Aug;15(4):590-600. doi: 10.1007/s12015-019-09881-8.

PMID:
30879244
5.

Recipients with blood group A associated with longer survival rates in cardiac valvular bioprostheses.

Schussler O, Lila N, Perneger T, Mootoosamy P, Grau J, Francois A, Smadja DM, Lecarpentier Y, Ruel M, Carpentier A.

EBioMedicine. 2019 Apr;42:54-63. doi: 10.1016/j.ebiom.2019.02.047. Epub 2019 Mar 14.

6.

[Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version].

Sanchez O, Benhamou Y, Bertoletti L, Constant J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Feb;36(2):249-283. doi: 10.1016/j.rmr.2019.01.003. Epub 2019 Feb 22. French. No abstract available.

PMID:
30799126
7.

Endoglin as an Adhesion Molecule in Mature and Progenitor Endothelial Cells: A Function Beyond TGF-β.

Rossi E, Bernabeu C, Smadja DM.

Front Med (Lausanne). 2019 Jan 30;6:10. doi: 10.3389/fmed.2019.00010. eCollection 2019. Review.

8.

Cannabidiol Increases Proliferation, Migration, Tubulogenesis, and Integrity of Human Brain Endothelial Cells through TRPV2 Activation.

Luo H, Rossi E, Saubamea B, Chasseigneaux S, Cochois V, Choublier N, Smirnova M, Glacial F, Perrière N, Bourdoulous S, Smadja DM, Menet MC, Couraud PO, Cisternino S, Declèves X.

Mol Pharm. 2019 Mar 4;16(3):1312-1326. doi: 10.1021/acs.molpharmaceut.8b01252. Epub 2019 Feb 5.

PMID:
30721081
9.

Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity.

Blandinières A, Gendron N, Bacha N, Bièche I, Chocron R, Nunes H, Nevo N, Rossi E, Crestani B, Lecourt S, Chevret S, Lokajczyk A, Mignon V, Kisaoglu A, Juvin K, Bertil S, Valeyre D, Cras A, Gaussem P, Israël-Biet D, Smadja DM.

Angiogenesis. 2019 May;22(2):325-339. doi: 10.1007/s10456-018-09659-5. Epub 2019 Jan 3.

PMID:
30607696
10.

Osteoprotegerin Induces CD34+ Differentiation in Endothelial Progenitor Cells.

Boisson-Vidal C, Benslimane-Ahmim Z, Lokajczyk A, Heymann D, Smadja DM.

Front Med (Lausanne). 2018 Nov 27;5:331. doi: 10.3389/fmed.2018.00331. eCollection 2018.

11.

Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension.

Bacha NC, Levy M, Guerin CL, Le Bonniec B, Harroche A, Szezepanski I, Renard JM, Gaussem P, Israel-Biet D, Boulanger CM, Smadja DM.

Pediatr Pulmonol. 2019 Jan;54(1):66-72. doi: 10.1002/ppul.24190. Epub 2018 Nov 28.

PMID:
30485728
12.

Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation.

Martin AC, Godier A, Narayanan K, Smadja DM, Marijon E.

Circulation. 2018 Aug 7;138(6):627-633. doi: 10.1161/CIRCULATIONAHA.117.033326. Review.

PMID:
30354610
13.

[Venous thromboembolism and urological cancer: Epidemiology and therapeutically management].

Felber M, Rozet F, Droupy S, Misraï V, Smadja DM, Rouprêt M.

Prog Urol. 2019 Jan;29(1):1-11. doi: 10.1016/j.purol.2018.09.002. Epub 2018 Oct 10. French.

PMID:
30316671
14.

Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice.

Blandinières A, Gille T, Sadoine J, Bièche I, Slimani L, Dizier B, Gaussem P, Chaussain C, Planes C, Dorfmüller P, Israël-Biet D, Smadja DM.

Stem Cell Rev Rep. 2018 Dec;14(6):812-822. doi: 10.1007/s12015-018-9846-5.

PMID:
30267203
15.

Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month.

Eyraud D, Suner L, Dupont A, Bachelot-Loza C, Smadja DM, Helley D, Bertil S, Gostian O, Szymezak J, Loncar Y, Puybasset L, Lebray P, Vezinet C, Vaillant JC, Granger B, Gaussem P.

PLoS One. 2018 Aug 2;13(8):e0200364. doi: 10.1371/journal.pone.0200364. eCollection 2018.

16.

CD34+ Hematopoietic Stem Cell Count Is Predictive of Vascular Event Occurrence in Children with Sickle Cell Disease.

Kossorotoff M, De Montalembert M, Brousse V, Lasne D, Curis E, Smadja DM, Lacroix R, Bertil S, Masson E, Desguerre I, Bonnet D, Gaussem P.

Stem Cell Rev Rep. 2018 Oct;14(5):694-701. doi: 10.1007/s12015-018-9835-8.

PMID:
29931411
17.

Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support.

Vincent F, Rauch A, Loobuyck V, Robin E, Nix C, Vincentelli A, Smadja DM, Leprince P, Amour J, Lemesle G, Spillemaeker H, Debry N, Latremouille C, Jansen P, Capel A, Moussa M, Rousse N, Schurtz G, Delhaye C, Paris C, Jeanpierre E, Dupont A, Corseaux D, Rosa M, Sottejeau Y, Barth S, Mourran C, Gomane V, Coisne A, Richardson M, Caron C, Preda C, Ung A, Carpentier A, Hubert T, Denis C, Staels B, Lenting PJ, Van Belle E, Susen S.

J Am Coll Cardiol. 2018 May 15;71(19):2106-2118. doi: 10.1016/j.jacc.2018.02.075.

18.

Usefulness of initial plasma dabigatran concentration to predict rebound after reversal.

Gendron N, Gay J, Lemoine M, Gaussem P, Lillo-Le-Louet A, Smadja DM.

Haematologica. 2018 May;103(5):e226-e229. doi: 10.3324/haematol.2017.183400. Epub 2018 Feb 22. No abstract available.

19.

The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin.

Arrigo M, Vodovar N, Nougué H, Sadoune M, Pemberton CJ, Ballan P, Ludes PO, Gendron N, Carpentier A, Cholley B, Bizouarn P, Cohen-Solal A, Singh JP, Szymonifka J, Latremouille C, Samuel JL, Launay JM, Pottecher J, Richards AM, Truong QA, Smadja DM, Mebazaa A.

Eur Heart J. 2018 May 21;39(20):1794-1798. doi: 10.1093/eurheartj/ehx679.

PMID:
29244074
20.

Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis.

Bacha NC, Blandinieres A, Rossi E, Gendron N, Nevo N, Lecourt S, Guerin CL, Renard JM, Gaussem P, Angles-Cano E, Boulanger CM, Israel-Biet D, Smadja DM.

Stem Cell Rev Rep. 2018 Apr;14(2):223-235. doi: 10.1007/s12015-017-9778-5.

PMID:
29101610
21.

Human endoglin as a potential new partner involved in platelet-endothelium interactions.

Rossi E, Pericacho M, Bachelot-Loza C, Pidard D, Gaussem P, Poirault-Chassac S, Blanco FJ, Langa C, González-Manchón C, Novoa JML, Smadja DM, Bernabeu C.

Cell Mol Life Sci. 2018 Apr;75(7):1269-1284. doi: 10.1007/s00018-017-2694-7. Epub 2017 Oct 28.

22.

A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot study.

Latrémouille C, Carpentier A, Leprince P, Roussel JC, Cholley B, Boissier E, Epailly E, Capel A, Jansen P, Smadja DM.

J Heart Lung Transplant. 2018 Jan;37(1):33-37. doi: 10.1016/j.healun.2017.09.002. Epub 2017 Sep 14.

PMID:
28986001
23.

Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells.

d'Audigier C, Susen S, Blandinieres A, Mattot V, Saubamea B, Rossi E, Nevo N, Lecourt S, Guerin CL, Dizier B, Gendron N, Caetano B, Gaussem P, Soncin F, Smadja DM.

Stem Cell Rev Rep. 2018 Feb;14(1):82-91. doi: 10.1007/s12015-017-9775-8.

PMID:
28980146
24.

Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.

Ruiz-Llorente L, Gallardo-Vara E, Rossi E, Smadja DM, Botella LM, Bernabeu C.

Expert Opin Ther Targets. 2017 Oct;21(10):933-947. doi: 10.1080/14728222.2017.1365839. Epub 2017 Aug 20. Review. Erratum in: Expert Opin Ther Targets. 2017 Oct;21(10 ):995.

PMID:
28796572
25.

Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism.

Rossi E, Smadja D, Goyard C, Cras A, Dizier B, Bacha N, Lokajczyk A, Guerin CL, Gendron N, Planquette B, Mignon V, Bernabéu C, Sanchez O, Smadja DM.

Thromb Haemost. 2017 Oct 5;117(10):1908-1918. doi: 10.1160/TH17-01-0007. Epub 2017 Aug 3.

PMID:
28771278
26.

Bioprosthetic Total Artificial Heart Induces a Profile of Acquired Hemocompatibility With Membranes Recellularization.

Smadja DM, Saubaméa B, Susen S, Kindo M, Bruneval P, Van Belle E, Jansen P, Roussel JC, Latrémouille C, Carpentier A.

J Am Coll Cardiol. 2017 Jul 18;70(3):404-406. doi: 10.1016/j.jacc.2017.05.021. No abstract available.

27.

[State of the art: Direct oral anticoagulants and transfusion].

Martin AC, Godier A, Smadja DM, Mauge L, Fischer AM.

Transfus Clin Biol. 2017 Sep;24(3):154-159. doi: 10.1016/j.tracli.2017.05.019. Epub 2017 Jun 30. Review. French.

PMID:
28673500
28.

The Carmat Bioprosthetic Total Artificial Heart Is Associated With Early Hemostatic Recovery and no Acquired von Willebrand Syndrome in Calves.

Smadja DM, Susen S, Rauch A, Cholley B, Latrémouille C, Duveau D, Zilberstein L, Méléard D, Boughenou MF, Belle EV, Gaussem P, Capel A, Jansen P, Carpentier A.

J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1595-1602. doi: 10.1053/j.jvca.2017.02.184. Epub 2017 Mar 1.

PMID:
28648774
29.

Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia.

Sloma I, Mitjavila-Garcia MT, Feraud O, Griscelli F, Oudrhiri N, El Marsafy S, Gobbo E, Divers D, Proust A, Smadja DM, Desterke C, Carles A, Ma Y, Hirst M, Marra MA, Eaves CJ, Bennaceur-Griscelli A, Turhan AG.

Exp Hematol. 2017 Sep;53:48-58. doi: 10.1016/j.exphem.2017.05.007. Epub 2017 Jun 8.

PMID:
28602946
30.

[The role of extracorporeal removal of CO2 (ECCO2R) in the management of respiratory diseases].

Diehl JL, Boisramé-Helms J, Chardon-Couteau A, Commereuc M, Augy JL, Sokoloff A, Rivet N, Gaussem P, Smadja DM, Aissaoui N.

Rev Mal Respir. 2017 Jun;34(6):598-606. doi: 10.1016/j.rmr.2017.02.003. Epub 2017 May 12. Review. French.

PMID:
28506729
31.

Human very Small Embryonic-like Cells Support Vascular Maturation and Therapeutic Revascularization Induced by Endothelial Progenitor Cells.

Guerin CL, Rossi E, Saubamea B, Cras A, Mignon V, Silvestre JS, Smadja DM.

Stem Cell Rev Rep. 2017 Aug;13(4):552-560. doi: 10.1007/s12015-017-9731-7.

PMID:
28303468
32.

Very Small Embryonic-like Stem Cells Are Mobilized in Human Peripheral Blood during Hypoxemic COPD Exacerbations and Pulmonary Hypertension.

Guerin CL, Blandinières A, Planquette B, Silvestre JS, Israel-Biet D, Sanchez O, Smadja DM.

Stem Cell Rev Rep. 2017 Aug;13(4):561-566. doi: 10.1007/s12015-017-9732-6.

PMID:
28285391
33.

Real-world use of idarucizumab for dabigatran reversal in three cases of serious bleeding.

Gendron N, Feral-Pierssens AL, Jurcisin I, de Raucourt E, Bouton V, Fischer AM, Lorenceau-Savale C, Lillo-Le Louët A, Smadja DM.

Clin Case Rep. 2017 Feb 10;5(3):346-350. doi: 10.1002/ccr3.839. eCollection 2017 Mar.

34.

Bone Marrow Very Small Embryonic-Like Stem Cells: New Generation of Autologous Cell Therapy Soon Ready for Prime Time?

Smadja DM.

Stem Cell Rev Rep. 2017 Apr;13(2):198-201. doi: 10.1007/s12015-017-9718-4.

PMID:
28101702
35.

PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study.

Bruzelius M, Iglesias MJ, Hong MG, Sanchez-Rivera L, Gyorgy B, Souto JC, Frånberg M, Fredolini C, Strawbridge RJ, Holmström M, Hamsten A, Uhlén M, Silveira A, Soria JM, Smadja DM, Butler LM, Schwenk JM, Morange PE, Trégouët DA, Odeberg J.

Blood. 2016 Dec 8;128(23):e59-e66. Epub 2016 Oct 14.

PMID:
27742707
36.

Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database.

Trinh-Duc A, Lillo-Le Louët A, Tellier E, Viard T, Le Gal G, Smadja DM.

Thromb Res. 2016 Oct;146:43-45. doi: 10.1016/j.thromres.2016.08.014. Epub 2016 Aug 24. No abstract available.

PMID:
27579488
37.

Circulating endothelial cells: a new biomarker of endothelial dysfunction in hematological diseases.

Gendron N, Smadja DM.

Ann Biol Clin (Paris). 2016 Aug 1;74(4):395-404. doi: 10.1684/abc.2016.1160. Review.

38.

[Direct oral anticoagulants: what is the exact assessment of coagulation tests and plasma levels by laboratory tests in clinical practice?].

Gendron N, Smadja DM.

Ann Biol Clin (Paris). 2016 Jan-Feb;74(1):69-77. doi: 10.1684/abc.2015.1110. Review. French.

39.

Endoglin regulates mural cell adhesion in the circulatory system.

Rossi E, Smadja DM, Boscolo E, Langa C, Arevalo MA, Pericacho M, Gamella-Pozuelo L, Kauskot A, Botella LM, Gaussem P, Bischoff J, Lopez-Novoa JM, Bernabeu C.

Cell Mol Life Sci. 2016 Apr;73(8):1715-39. doi: 10.1007/s00018-015-2099-4. Epub 2015 Dec 8.

40.

[Direct oral anticoagulants: what is the exact assessment of coagulation tests and plasma levels by laboratory tests in clinical practice?].

Gendron N, Smadja DM.

Ann Biol Clin (Paris). 2015 Nov;73 Suppl 1:26-8. doi: 10.1684/abc.2015.1085. French. No abstract available.

PMID:
26620243
41.

[Circulating endothelial cells: new biomarker of the endothelial dysfunction in hematological malignancies].

Gendron N, Smadja DM.

Ann Biol Clin (Paris). 2015 Nov;73 Suppl 1:14-6. doi: 10.1684/abc.2015.1080. French. No abstract available.

PMID:
26620238
42.

First clinical use of a bioprosthetic total artificial heart: report of two cases.

Carpentier A, Latrémouille C, Cholley B, Smadja DM, Roussel JC, Boissier E, Trochu JN, Gueffet JP, Treillot M, Bizouarn P, Méléard D, Boughenou MF, Ponzio O, Grimmé M, Capel A, Jansen P, Hagège A, Desnos M, Fabiani JN, Duveau D.

Lancet. 2015 Oct 17;386(10003):1556-63. doi: 10.1016/S0140-6736(15)60511-6. Epub 2015 Jul 28.

PMID:
26231456
43.

Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells.

Smadja DM, Levy M, Huang L, Rossi E, Blandinières A, Israel-Biet D, Gaussem P, Bischoff J.

Thromb Haemost. 2015 Oct;114(4):735-47. doi: 10.1160/TH14-11-0907. Epub 2015 Jun 11.

44.

Thrombin receptor PAR-1 activation on endothelial progenitor cells enhances chemotaxis-associated genes expression and leukocyte recruitment by a COX-2-dependent mechanism.

d'Audigier C, Cochain C, Rossi E, Guérin CL, Bièche I, Blandinières A, Marsac B, Silvestre JS, Gaussem P, Smadja DM.

Angiogenesis. 2015 Jul;18(3):347-59. doi: 10.1007/s10456-015-9471-8. Epub 2015 May 31.

PMID:
26026674
45.

Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.

Germain M, Chasman DI, de Haan H, Tang W, Lindström S, Weng LC, de Andrade M, de Visser MC, Wiggins KL, Suchon P, Saut N, Smadja DM, Le Gal G, van Hylckama Vlieg A, Di Narzo A, Hao K, Nelson CP, Rocanin-Arjo A, Folkersen L, Monajemi R, Rose LM, Brody JA, Slagboom E, Aïssi D, Gagnon F, Deleuze JF, Deloukas P, Tzourio C, Dartigues JF, Berr C, Taylor KD, Civelek M, Eriksson P; Cardiogenics Consortium, Psaty BM, Houwing-Duitermaat J, Goodall AH, Cambien F, Kraft P, Amouyel P, Samani NJ, Basu S, Ridker PM, Rosendaal FR, Kabrhel C, Folsom AR, Heit J, Reitsma PH, Trégouët DA, Smith NL, Morange PE.

Am J Hum Genet. 2015 Apr 2;96(4):532-42. doi: 10.1016/j.ajhg.2015.01.019. Epub 2015 Mar 12.

46.

Bone-marrow-derived very small embryonic-like stem cells in patients with critical leg ischaemia: evidence of vasculogenic potential.

Guerin CL, Loyer X, Vilar J, Cras A, Mirault T, Gaussem P, Silvestre JS, Smadja DM.

Thromb Haemost. 2015 May;113(5):1084-94. doi: 10.1160/TH14-09-0748. Epub 2015 Jan 22.

PMID:
25608764
47.

Increase in both angiogenic and angiostatic mediators in patients with idiopathic pulmonary fibrosis.

Smadja DM, Nunes H, Juvin K, Bertil S, Valeyre D, Gaussem P, Israel-Biet D.

Pathol Biol (Paris). 2014 Dec;62(6):391-4. doi: 10.1016/j.patbio.2014.07.006. Epub 2014 Sep 16.

PMID:
25239280
48.

Impact of aspirin and clopidogrel interruption on platelet function in patients undergoing major vascular surgery.

Le Manach Y, Kahn D, Bachelot-Loza C, Le Sache F, Smadja DM, Remones V, Loriot MA, Coriat P, Gaussem P.

PLoS One. 2014 Aug 20;9(8):e104491. doi: 10.1371/journal.pone.0104491. eCollection 2014.

49.

Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathway.

Smadja DM, Dorfmüller P, Guerin CL, Bieche I, Badoual C, Boscolo E, Kambouchner M, Cazes A, Mercier O, Humbert M, Gaussem P, Bischoff J, Israël-Biet D.

Thromb Haemost. 2014 Nov;112(5):1002-13. doi: 10.1160/TH13-08-0711. Epub 2014 Aug 7.

50.

Neutrophils as new conductors of vascular homeostasis.

Smadja DM.

J Thromb Haemost. 2014 Jul;12(7):1166-9. doi: 10.1111/jth.12585. No abstract available.

Supplemental Content

Loading ...
Support Center